QUESTION 1: Identify and discuss the key legislative, policy and demographic drivers that underpin the introduction of the Free-Style Libre blood glucose monitoring device to diabetic patients in the...

NURSING CASE STUDY
INNOVATION AND ENTREPRENEURSHIP IN HEALTHCARE
Table of Contents
Answer to Question 1:    3
Key Legislations    3
Policies    4
Demographic Drivers    5
Answer to Question 2:    6
Lack of Awareness    6
Lack of Training    7
Lack of Control    9
References    11
Answer to Question 1:
This question identifies and discusses the key legislative, policy, and demographic drivers that underpin the introduction of the Freestyle Li
e blood glucose-monitoring device to diabetic patients withinFa
ingdon Community Healthcare Trusts.
In the case study, it has been found that since 1996, the number of patients who have diabetes has increased from 1.4 to 3.5 million in the UK.
However, around 5 million people have yet to remain for the test. This situation causes a major risk for the community to assess the rate of glucose in the blood. According to the case study, more than fifty per cent of the UK population is suffering from diabetes type 1, and about 42% of the population is suffering from diabetes type 2. Nevertheless, this situation concluded that the cause of diabetes is increasing and it causes a burden for the individual and the societal community of the UK. This situation, therefore, represents a lack of formative awareness for diabetes prevention in the UK.
In this context, a non-invasive device called Freestyle Li
e Blood Glucose Device for monitoring has a
ived to reduce the burden of the community. Nonetheless, the technology includes a sensor that can transfer the information of glucose rate present in the blood to the android mobile application of the patient. Similarly, the information doesreach the associates' healthcare professionals and the patients connected through the application.The demographic drivers, in this case, include the peoplebelonging to age groups of 40 and above that, who are majorly affected by the onset of diabetes and their harmful symptoms.
Key Legislations
Several legislations driversunderpin the introduction of Freestyle Li
e blood glucose monitoring device to the diabetic patient, such as the Care Act 2014, the Health and Social Care Act 2012, and The Medicines and Healthcare Products Regulatory Agency to the diabetic patient. According to Care Act 2014, health care professionals have approached the needs of individual well-being that introduced Freestyle Li
e for diabetic patients.
The key principle of certain legislation explores and promotes the information that a freestyle li
e blood glucose-monitoring device is used to measure the level of interstitial fluid glucose in the blood that leads to negative health issues in the human body (Manthorpe, 2021). At the same time, it provides the associated advice on providing care and support to the patients who have type1 diabetes in the UK.
Furthermore, the legislation has highlighted that healthcare professionals need to promote and enhance supportive care systems and explore the detailed information about the device so that the introduction of Freestyle Li
e so that the population of the UK can be privileged. In this context, the Health and Social Care Act 2012 also appears as the key legislation that encourages the health professionals and the innovators of Freestyle Li
e monitoring devices that play a major role to sustain the newer medical services.The Rogers Diffusion Model may be the best method to augment awareness among the common people. According to the model, the device's use and application will be provided to the public. Consequently, the volunteers for implementing the use will be developed, and the awareness will gradually increase.
In this context, the professionals have provided sufficient information and advantages of the device for the UK community so that the reduction of the increasing percentage of a person with diabetes can be preserved (Fernandez et al., 2021). Furthermore, the introduction of the Freestyle Li
e, Medicines and Healthcare Products Regulatory Agency has also played a significant role as it provides safety provisions for the acceptance of the device that the majority of the UK population who are suffering from diabetes can be privileged by this device. The innovation model in this case may be beneficial for the organisations implementing the care services to ensure that the innovative methods and intellect are implemented in order to develop the instances of innovation while implementing the aspect of the Li
e device.
Policies
As per the Fa
ingdon Community Healthcare Trust, different policies underpin the introduction of Freestyle Li
e blood glucose monitoring devices to diabetic patients, such as the UK Government Innovation Policy. Furthermore, the legislation of King's Fund can also act as the driver that underpins the introduction of Freestyle Li
e and measures the glucose level in the blood. In this context, the King's Fund works to improve healthcare and services. However, the major aim of the organisation is to improve the medical status ofthe UK to the most innovative place where innovative talent is considered and promoted in terms of healthcare (Bailey, West and King's Fund,2020).
Therefore, it can play a greater role in the introduction of Freestyle Li
e that can play a greater role to reduce the rate of diabetic patients in the UK. Furthermore, the King’sFund has approached several research and development programs and highlighted the functional activities of the Freestyle Li
e that can store the data and the information about the level of glucose present in blood and help the patients’ type 1 diabetic patient.
The policy of King's Fund helped to introduce the Freestyle Li
e to track the level of glucose without finger pricks. Nevertheless, it is the monitoring system of glucose, which is based on sense and readers. Regarding the case study, the adults with type 1 diabetes need to test 4th times a day (Cu
y and Ham, 2020). In this context, they must take their test through the device before each meal they take and the bedtime.
At the same time, the test can be approached with 10 minutes intervals in the case of pregnancy, sports, or during illness. Not only that, but also the test can be approached ten times a day in a certain circumstance when the patient is involved in a long travel or associated with that kind of profession. On the other hand, children, young and aged people who have diabetes type 1 in the UK require attention coveringfive capillary blood glucose tests in one day.
Similarly, the test should be frequent with the physical activity or children's illness. In this context, the continuous blood glucose test can be offered to young children with impaired hypoglycaemia awareness. The device is also considered to be used for infants. However, the policy of the King's Fund is to stimulate innovative ideas of implementing Freestyle Li
e that are innovative and provide more privileges to the diabetic patients to track the glucose level in the blood, which can control their...